Sanofi, headquartered in Paris, France, is a global pharmaceutical company that specializes in research, development, manufacturing, and marketing of innovative healthcare products. Founded in 1973, Sanofi has a rich history that spans over a century, dating back to the establishment of its predecessors. The company's headquarters, known as the Sanofi Campus, is located in Paris, France. The spacious campus, covering an area of 241,000 square meters, serves as a hub for the company's administrative, research, and development activities. It houses state-of-the-art laboratories, manufacturing facilities, and office spaces. Sanofi operates in multiple therapeutic areas, offering a wide range of pharmaceutical products and services. It focuses on finding solutions for prevalent diseases such as diabetes, cardiovascular diseases, rare diseases, multiple sclerosis, and cancer. Additionally, the company provides vaccines, consumer healthcare products, and innovative solutions in areas like digital health and emerging markets. With a strong global presence, Sanofi operates through a network of subsidiaries, joint ventures, and partnerships. Noteworthy subsidiaries include Genzyme, a leading biotechnology company acquired by Sanofi in 2011, and Sanofi Pasteur, the vaccines division of the company. Sanofi also has extensive joint ventures and partnerships with various organizations around the world, allowing it to expand its reach and collaborative efforts in research and development. Sanofi has established itself as one of the top pharmaceutical companies globally. It consistently ranks among the industry leaders in terms of revenue and market capitalization. In terms of global sales, Sanofi generated revenues of €36.1 billion in 2020, further solidifying its position as one of the largest pharmaceutical companies worldwide. The company has achieved significant milestones and made notable strategic moves in recent years. In 2021, Sanofi announced a strategic shift towards becoming a leader in immunology and rare diseases. This involves focusing on developing breakthrough therapies, expanding research and development efforts, and pursuing targeted acquisitions and partnerships. As of the latest updates, Sanofi continues to pursue its growth strategy by investing in research and development, exploring innovative collaborations, and expanding its product portfolio. The company remains dedicated to addressing global health challenges and improving the lives of patients worldwide through its cutting-edge healthcare solutions.